2021/09/03 ALA-1000 Receive notice of patent allowance from Taiwan Intellectual Property Office (TIPO), Application No. 106131215.Post author:alarpharmPost published:7 . 9 . 2021Post category:Media releases You Might Also Like 2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895). 21 . 4 . 2021 2024/02/22 ALA-3000 has received a notice of allowance from Japan Patent Office (JPO) after examination. (Patent Application No. 2021-540341) 29 . 2 . 2024 2020/08/03 ALA -1000 Receive notice of patent allowance from the IP Australia. 25 . 8 . 2020 2022/05/12 ALA-1000 Received notice of patent allowance from European Patent Office (EPO) , Application No. 17850245.6 13 . 5 . 2022 2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022
2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895). 21 . 4 . 2021
2024/02/22 ALA-3000 has received a notice of allowance from Japan Patent Office (JPO) after examination. (Patent Application No. 2021-540341) 29 . 2 . 2024
2022/05/12 ALA-1000 Received notice of patent allowance from European Patent Office (EPO) , Application No. 17850245.6 13 . 5 . 2022
2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022